Income Statement Japan Tobacco Inc.

Equities

2914

JP3726800000

Tobacco

Market Closed - Japan Exchange Other stock markets 06:30:00 15/12/2025 GMT			5-day change	1st Jan Change
5,841.00 ^JPY	+1.23%		+1.51%	+43.16%

12-01	Shionogi & Co Completes Acquisition of Japan Tobacco's Pharma Business	MT
12-01	Japan Tobacco Completes Pharmaceutical Business Transfer to Shionogi	MT

302683097566f03748cb3f696ffe2b.XX3x1T9u1YZWrhssWiIIHdzvkVEZ5Ntoczsv8qdyYX4.bz6pvggF5ORvwER2D1hcVpvfpCBd1IEDIwtDpOkrVi4aEouhSimv3APPaA

Published financial data: JAPAN TOBACCO INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	2,093B	2,325B	2,658B	2,841B	3,150B
Total Revenues	2,093B	2,325B	2,658B	2,841B	3,150B
Cost of Goods Sold, Total	898B	957B	1,091B	1,226B	1,407B
Gross Profit	1,195B	1,368B	1,567B	1,615B	1,742B
Selling General & Admin Expenses, Total	600B	715B	756B	801B	1,280B
R&D Expenses	60.85B	65.02B	70.81B	75.1B	78.61B
Depreciation & Amortization - (IS)	104B	109B	114B	105B	105B
Other Operating Expenses	-8.27B	-7.4B	-11.36B	-11.08B	-22.35B
Other Operating Expenses, Total	756B	881B	930B	970B	1,441B
Operating Income	439B	487B	637B	645B	302B
Interest Expense, Total	-22.53B	-23.05B	-27.02B	-28.49B	-42.48B
Interest And Investment Income	7.32B	13.37B	26.54B	42.82B	67.56B
Net Interest Expenses	-15.22B	-9.68B	-485M	14.32B	25.08B
Income (Loss) On Equity Invest.	4.04B	4B	8.01B	8.33B	12.88B
Currency Exchange Gains (Loss)	-35.81B	-15.56B	-35.08B	-51.88B	-81.81B
Other Non Operating Income (Expenses)	4.21B	-1.39B	-24.56B	-13.25B	-32.96B
EBT, Excl. Unusual Items	396B	464B	585B	603B	225B
Restructuring Charges	1.69B	-	-	-	-
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	34.62B	8.22B	8.9B	18.95B	8.85B
Asset Writedown	-12.24B	-	-	-	-
EBT, Incl. Unusual Items	420B	472B	593B	622B	234B
Income Tax Expense	108B	132B	149B	136B	51.17B
Earnings From Continuing Operations	312B	340B	444B	485B	183B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	312B	340B	444B	485B	183B
Minority Interest	-1.78B	-1.69B	-1.46B	-3.02B	-3.36B
Net Income - (IS)	310B	338B	443B	482B	179B
Net Income to Common Incl Extra Items	310B	338B	443B	482B	179B
Net Income to Common Excl. Extra Items	310B	338B	443B	482B	179B
Per Share Items
Net EPS - Basic	174.88	190.76	249.45	271.69	100.95
Basic EPS - Continuing Operations	174.88	190.76	249.45	271.69	100.95
Basic Weighted Average Shares Outstanding	1.77B	1.77B	1.77B	1.78B	1.78B
Net EPS - Diluted	174.8	190.68	249.36	271.63	100.94
Diluted EPS - Continuing Operations	174.8	190.68	249.36	271.63	100.94
Diluted Weighted Average Shares Outstanding	1.77B	1.78B	1.78B	1.78B	1.78B
Normalized Basic EPS	138.5	162.54	205.03	210.48	77.28
Normalized Diluted EPS	138.44	162.47	204.96	210.43	77.27
Dividend Per Share	154	140	188	194	194
Payout Ratio	88.04	74.43	60.12	76.16	195.07
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	607B	674B	836B	825B	482B
EBITA	505B	487B	637B	645B	302B
EBIT	439B	487B	637B	645B	302B
EBITDAR	616B	-	-	-	-
Effective Tax Rate - (Ratio)	25.72	27.99	25.15	21.93	21.89
Total Current Taxes	111B	-	-	-	-
Total Deferred Taxes	-3.11B	-	-	-	-
Normalized Net Income	246B	288B	364B	374B	137B
Interest on Long-Term Debt	1.46B	-	-	-	-
Non-Cash Pension Expense	5.22B	3.95B	3.88B	7.8B	5.8B
Supplemental Operating Expense Items
Advertising Expense	119B	138B	154B	180B	220B
Selling and Marketing Expenses	177B	205B	233B	259B	302B
Research And Development Expense From Footnotes	60.85B	65.02B	70.81B	75.1B	78.61B
Net Rental Expense, Total	9.17B	-	-	-	-
Imputed Operating Lease Interest Expense	1.61B	-	-	-	-
Imputed Operating Lease Depreciation	7.56B	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	593M	-	-	-	-
Total Stock-Based Compensation	593M	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	539B	722B	867B	1,040B	1,085B
Short Term Investments	18.83B	-	-	-	-
Total Cash And Short Term Investments	558B	722B	867B	1,040B	1,085B
Accounts Receivable, Total	403B	457B	477B	535B	569B
Other Receivables	24.31B	19.03B	21.9B	21.8B	-
Total Receivables	427B	476B	499B	557B	569B
Inventory	540B	563B	692B	833B	957B
Prepaid Expenses	352B	18.34B	18.73B	20.85B	-
Other Current Assets, Total	128B	542B	647B	809B	967B
Total Current Assets	2,004B	2,321B	2,724B	3,260B	3,578B
Gross Property Plant And Equipment	1,715B	-	-	-	-
Accumulated Depreciation	-955B	-	-	-	-
Net Property Plant And Equipment	759B	756B	776B	821B	908B
Long-term Investments	147B	209B	265B	288B	301B
Goodwill	1,909B	2,061B	2,446B	2,616B	2,914B
Other Intangibles, Total	364B	307B	246B	207B	486B
Deferred Tax Assets Long-Term	123B	120B	91.43B	89.38B	184B
Other Long-Term Assets, Total	75.27B	-	-1M	-	-
Total Assets	5,381B	5,774B	6,548B	7,282B	8,371B
Liabilities
Accounts Payable, Total	234B	556B	540B	593B	660B
Accrued Expenses, Total	3.7B	-	-	-	-
Short-term Borrowings	51.63B	70.64B	63.73B	209B	60.32B
Current Portion of Long-Term Debt	89.84B	72.26B	73.58B	24.36B	118B
Current Portion of Leases	17.25B	-	-	-	-
Current Income Taxes Payable	46.46B	30.79B	37.47B	29.65B	24.62B
Other Current Liabilities	881B	771B	848B	1,071B	1,286B
Total Current Liabilities	1,324B	1,500B	1,563B	1,927B	2,149B
Long-Term Debt	817B	776B	821B	909B	1,548B
Long-Term Leases	49.28B	-	-	-	-
Pension & Other Post Retirement Benefits	332B	296B	244B	279B	277B
Deferred Tax Liability Non Current	64.45B	69.96B	40.06B	40.59B	124B
Other Non Current Liabilities	195B	246B	264B	213B	424B
Total Liabilities	2,782B	2,888B	2,931B	3,370B	4,522B
Common Stock, Total	100B	100B	100B	100B	100B
Additional Paid In Capital	736B	736B	736B	736B	737B
Retained Earnings	2,784B	2,864B	3,090B	3,192B	3,037B
Treasury Stock	-492B	-491B	-490B	-489B	-489B
Comprehensive Income and Other	-606B	-400B	104B	291B	382B
Total Common Equity	2,523B	2,809B	3,540B	3,830B	3,767B
Minority Interest	76.66B	76.82B	76.33B	82.34B	82.1B
Total Equity	2,599B	2,886B	3,617B	3,912B	3,849B
Total Liabilities And Equity	5,381B	5,774B	6,548B	7,282B	8,371B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.77B	1.77B	1.77B	1.78B	1.78B
ECS Total Common Shares Outstanding	1.77B	1.77B	1.77B	1.78B	1.78B
Book Value / Share	1.42K	1.58K	1.99K	2.16K	2.12K
Tangible Book Value	250B	441B	848B	1,007B	366B
Tangible Book Value Per Share	140.81	248.6	477.75	567.08	206.08
Total Debt	1,025B	919B	958B	1,142B	1,727B
Net Debt	468B	197B	91.43B	102B	642B
Debt Equivalent of Unfunded Proj. Benefit Obligation	261B	243B	186B	214B	188B
Debt Equivalent Oper. Leases	73.38B	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	76.66B	76.82B	76.33B	82.34B	82.1B
Equity Method Investments, Total	40.23B	41.72B	56.94B	56.73B	50.42B
Account Code - Inventory Valuation	6	-	-	-	-
Inventories - Raw Materials, Total	335B	349B	440B	520B	600B
Inventories - Finished Goods, Total	131B	135B	146B	190B	212B
Inventories - Others	74.25B	79.06B	106B	123B	146B
Land - (BS)	686B	-	-	-	-
Machinery, Total	979B	-	-	-	-
Full Time Employees	58.3K	55.38K	52.64K	53.24K	53.59K
Accumulated Allowance for Doubtful Accounts (Supple)	1.92B	1.31B	2.53B	3.9B	7.81B

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	310B	472B	593B	622B	234B
Depreciation & Amortization - CF	121B	187B	200B	180B	180B
Amortization of Goodwill and Intangible Assets - (CF)	66.29B	-	-	-	-
Depreciation & Amortization, Total	187B	187B	200B	180B	180B
Amortization of Deferred Charges, Total - (CF)	11.9B	-	-	-	-
(Gain) Loss From Sale Of Asset	-40.82B	18.79B	22.65B	-3.1B	10B
(Gain) Loss on Sale of Investments - (CF)	-	-	-849M	104M	-1.72B
Asset Writedown & Restructuring Costs	12.57B	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-4.04B	-4B	-8.01B	-8.33B	-12.88B
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	-24.11B	-132B	-191B	-159B	-155B
Change In Accounts Receivable	21.55B	-29.89B	26.57B	-30.17B	45.77B
Change In Inventories	748M	9.77B	-93.91B	-136B	-96.57B
Change In Accounts Payable	39.29B	141B	-24.72B	167B	-37.12B
Change in Other Net Operating Assets	5.07B	-64.42B	-39.59B	-65B	464B
Cash from Operations	520B	599B	484B	567B	630B
Capital Expenditure	-85.32B	-86.35B	-81.41B	-94.86B	-128B
Cash Acquisitions	-1.14B	-	-	-	-
Divestitures	-	2.56B	3.03B	1.37B	414M
Sale (Purchase) of Real Estate properties	86.26B	-	-	-	-
Sale (Purchase) of Intangible assets	-23.3B	-16.57B	-18B	-26.35B	-22.6B
Investment in Marketable and Equity Securities, Total	27.07B	-3.88B	-17.95B	-28.65B	-32.46B
Other Investing Activities, Total	1.78B	6.74B	12.51B	22.36B	-257B
Cash from Investing	5.35B	-97.5B	-102B	-126B	-440B
Short Term Debt Issued, Total	-	22.89B	-	143B	-
Long-Term Debt Issued, Total	222B	58.63B	70.7B	62.68B	679B
Total Debt Issued	222B	81.52B	70.7B	206B	679B
Short Term Debt Repaid, Total	-132B	-	-27.61B	-	-150B
Long-Term Debt Repaid, Total	-110B	-160B	-72.85B	-83.1B	-245B
Total Debt Repaid	-242B	-160B	-100B	-83.1B	-395B
Repurchase of Common Stock	-1M	-1M	-1M	-1M	-2M
Common Dividends Paid	-273B	-252B	-266B	-367B	-350B
Common & Preferred Stock Dividends Paid	-273B	-252B	-266B	-367B	-350B
Other Financing Activities, Total	-4.42B	-22.36B	-10.24B	-25.79B	-28.89B
Cash from Financing	-297B	-353B	-306B	-270B	-94.91B
Foreign Exchange Rate Adjustments	-46.1B	34.62B	69.35B	2.94B	-50.98B
Miscellaneous Cash Flow Adjustments	1M	-1M	-	-	-
Net Change in Cash	182B	183B	145B	173B	44.36B
Supplemental Items
Cash Interest Paid	19.55B	19.11B	23.73B	26.32B	33.98B
Cash Income Tax Paid (Refund)	125B	142B	194B	159B	161B
Levered Free Cash Flow	413B	413B	292B	350B	194B
Unlevered Free Cash Flow	427B	427B	309B	368B	220B
Change In Net Working Capital	-61.9B	-39.04B	189B	94.03B	-2.35B
Net Debt Issued / Repaid	-19.85B	-78.84B	-29.76B	123B	284B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	5.02	5.45	6.46	5.83	2.41
Return on Total Capital	7.41	8.19	9.5	8.37	3.55
Return On Equity %	11.68	12.4	13.66	12.89	4.71
Return on Common Equity	11.97	12.7	13.94	13.09	4.72
Margin Analysis
Gross Profit Margin %	57.09	58.84	58.95	56.85	55.32
SG&A Margin	28.65	30.74	28.46	28.2	40.63
EBITDA Margin %	28.98	28.99	31.47	29.03	15.29
EBITA Margin %	24.14	20.94	23.95	22.71	9.58
EBIT Margin %	20.97	20.94	23.95	22.71	9.58
Income From Continuing Operations Margin %	14.91	14.63	16.71	17.08	5.8
Net Income Margin %	14.83	14.56	16.66	16.98	5.69
Net Avail. For Common Margin %	14.83	14.56	16.66	16.98	5.69
Normalized Net Income Margin	11.74	12.41	13.69	13.15	4.36
Levered Free Cash Flow Margin	19.75	17.77	10.99	12.31	6.15
Unlevered Free Cash Flow Margin	20.43	18.39	11.62	12.94	7
Asset Turnover
Asset Turnover	0.38	0.42	0.43	0.41	0.4
Fixed Assets Turnover	2.68	3.07	3.47	3.56	3.64
Receivables Turnover (Average Receivables)	5.02	5.41	5.69	5.61	5.7
Inventory Turnover (Average Inventory)	1.6	1.74	1.74	1.61	1.57
Short Term Liquidity
Current Ratio	1.51	1.55	1.74	1.69	1.67
Quick Ratio	0.74	0.8	0.87	0.83	0.77
Operating Cash Flow to Current Liabilities	0.39	0.4	0.31	0.29	0.29
Days Sales Outstanding (Average Receivables)	72.87	67.46	64.12	65.04	64.16
Days Outstanding Inventory (Average Inventory)	228.94	210.36	209.95	226.94	232.72
Average Days Payable Outstanding	99.34	146.98	163.97	151.28	149.58
Cash Conversion Cycle (Average Days)	202.47	130.84	110.1	140.7	147.3
Long Term Solvency
Total Debt/Equity	39.45	31.83	26.5	29.2	44.87
Total Debt / Total Capital	28.29	24.14	20.95	22.6	30.97
LT Debt/Equity	33.34	26.88	22.7	23.23	40.22
Long-Term Debt / Total Capital	23.91	20.39	17.95	17.98	27.77
Total Liabilities / Total Assets	51.69	50.02	44.77	46.27	54.02
EBIT / Interest Expense	19.47	21.12	23.56	22.64	7.1
EBITDA / Interest Expense	27.79	29.23	30.95	28.95	11.34
(EBITDA - Capex) / Interest Expense	24	25.49	27.94	25.62	8.33
Total Debt / EBITDA	1.64	1.36	1.15	1.38	3.59
Net Debt / EBITDA	0.75	0.29	0.11	0.12	1.33
Total Debt / (EBITDA - Capex)	1.9	1.56	1.27	1.56	4.88
Net Debt / (EBITDA - Capex)	0.86	0.34	0.12	0.14	1.82
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-3.82	11.1	14.32	6.89	10.86
Gross Profit, 1 Yr. Growth %	-3.14	14.52	14.54	3.08	7.88
EBITDA, 1 Yr. Growth %	-5.41	11.1	24.11	-1.38	-41.61
EBITA, 1 Yr. Growth %	-6.76	-3.61	30.78	1.33	-53.23
EBIT, 1 Yr. Growth %	-6.42	10.95	30.78	1.33	-53.23
Earnings From Cont. Operations, 1 Yr. Growth %	-13.71	9.02	30.57	9.26	-62.38
Net Income, 1 Yr. Growth %	-10.9	9.1	30.79	8.94	-62.84
Normalized Net Income, 1 Yr. Growth %	-5.95	17.38	26.17	2.68	-63.28
Diluted EPS Before Extra, 1 Yr. Growth %	-10.76	9.08	30.77	8.93	-62.84
Accounts Receivable, 1 Yr. Growth %	-6.41	13.35	4.52	12.17	6.29
Inventory, 1 Yr. Growth %	-7.53	4.34	22.86	20.34	14.97
Net Property, Plant and Equip., 1 Yr. Growth %	-5.47	-0.45	2.66	5.87	10.49
Total Assets, 1 Yr. Growth %	-3.09	7.3	13.4	11.21	14.95
Tangible Book Value, 1 Yr. Growth %	13.73	76.57	92.21	18.73	-63.65
Common Equity, 1 Yr. Growth %	-5.25	11.35	26.03	8.18	-1.66
Cash From Operations, 1 Yr. Growth %	-3.81	15.21	-19.22	17.2	11.11
Capital Expenditures, 1 Yr. Growth %	-23.39	1.21	-5.72	16.52	34.69
Levered Free Cash Flow, 1 Yr. Growth %	30.9	-0.07	-29.3	19.79	-44.59
Unlevered Free Cash Flow, 1 Yr. Growth %	28.36	0	-27.73	19	-40.05
Dividend Per Share, 1 Yr. Growth %	0	-9.09	34.29	3.19	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-2.82	3.37	12.7	10.55	8.86
Gross Profit, 2 Yr. CAGR %	-3.51	5.32	14.53	8.66	5.45
EBITDA, 2 Yr. CAGR %	-8.2	2.51	17.43	10.63	-24.12
EBITA, 2 Yr. CAGR %	-9.95	-5.2	12.28	15.12	-31.16
EBIT, 2 Yr. CAGR %	-11.57	1.9	20.46	15.12	-31.16
Earnings From Cont. Operations, 2 Yr. CAGR %	-10.26	-3.01	19.31	19.44	-35.88
Net Income, 2 Yr. CAGR %	-10.31	-1.4	19.46	19.37	-36.37
Normalized Net Income, 2 Yr. CAGR %	-13.77	5.06	21.69	13.82	-38.59
Diluted EPS Before Extra, 2 Yr. CAGR %	-9.87	-1.33	19.44	19.35	-36.38
Accounts Receivable, 2 Yr. CAGR %	-6.08	3	8.85	8.28	9.19
Inventory, 2 Yr. CAGR %	-8.82	-1.77	13.22	21.59	17.62
Net Property, Plant and Equip., 2 Yr. CAGR %	0.03	-3	1.09	4.25	8.16
Total Assets, 2 Yr. CAGR %	-0.74	1.97	10.31	12.3	13.06
Tangible Book Value, 2 Yr. CAGR %	44.83	41.71	84.23	51.07	-34.31
Common Equity, 2 Yr. CAGR %	-2.07	2.72	18.46	16.76	3.14
Cash From Operations, 2 Yr. CAGR %	6.14	5.27	-3.53	-2.7	14.11
Capital Expenditures, 2 Yr. CAGR %	-21.54	-11.94	-2.32	4.81	25.28
Levered Free Cash Flow, 2 Yr. CAGR %	9.58	9.11	-15.95	-7.97	-18.53
Unlevered Free Cash Flow, 2 Yr. CAGR %	7.66	8.34	-14.99	-7.26	-15.53
Dividend Per Share, 2 Yr. CAGR %	1.32	-4.65	10.49	17.72	1.58
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-0.74	1.61	6.9	10.73	10.65
Gross Profit, 3 Yr. CAGR %	-2.68	2.16	8.31	10.58	8.4
EBITDA, 3 Yr. CAGR %	-2.89	-0.32	9.26	10.79	-10.6
EBITA, 3 Yr. CAGR %	-4.65	-2.28	5.53	8.5	-14.74
EBIT, 3 Yr. CAGR %	-6.09	-2.28	10.74	13.71	-14.74
Earnings From Cont. Operations, 3 Yr. CAGR %	-7.69	-4.24	7.09	15.86	-18.73
Net Income, 3 Yr. CAGR %	-7.53	-4.26	8.34	15.84	-19.1
Normalized Net Income, 3 Yr. CAGR %	-8.31	-1.93	11.67	14.99	-21.93
Diluted EPS Before Extra, 3 Yr. CAGR %	-7.23	-3.95	8.38	15.83	-19.11
Accounts Receivable, 3 Yr. CAGR %	-1.07	-0	3.5	9.94	7.61
Inventory, 3 Yr. CAGR %	-4.15	-4.63	5.83	15.54	19.34
Net Property, Plant and Equip., 3 Yr. CAGR %	0.61	-0.13	-1.15	2.66	6.29
Total Assets, 3 Yr. CAGR %	1.01	1.87	5.65	10.61	13.18
Tangible Book Value, 3 Yr. CAGR %	-13.89	54.72	56.87	59.13	-6.04
Common Equity, 3 Yr. CAGR %	-2.97	2.21	9.96	14.93	10.27
Cash From Operations, 3 Yr. CAGR %	7.43	9.08	-3.62	2.94	1.7
Capital Expenditures, 3 Yr. CAGR %	-11.65	-14.59	-9.92	3.6	13.95
Levered Free Cash Flow, 3 Yr. CAGR %	38.2	10.9	-5.58	-5.41	-22.29
Unlevered Free Cash Flow, 3 Yr. CAGR %	37.66	10.95	-5.34	-4.9	-19.81
Dividend Per Share, 3 Yr. CAGR %	3.23	-2.27	6.88	8	11.49
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-1.47	1.64	4.43	5.1	7.68
Gross Profit, 5 Yr. CAGR %	-2.17	1.48	3.87	4.71	7.15
EBITDA, 5 Yr. CAGR %	-3.42	0.36	4.78	3.93	-5.57
EBITA, 5 Yr. CAGR %	-4.34	-3.57	1.79	4.34	-11.04
EBIT, 5 Yr. CAGR %	-5.92	-1.83	3.75	4.34	-8.44
Earnings From Cont. Operations, 5 Yr. CAGR %	-4.98	-4.39	2.28	4.61	-12.77
Net Income, 5 Yr. CAGR %	-8.57	-4.3	2.44	4.57	-12.44
Normalized Net Income, 5 Yr. CAGR %	-8.06	-2.45	2.68	4.09	-12.09
Diluted EPS Before Extra, 5 Yr. CAGR %	-4.64	-4.12	2.63	4.77	-12.42
Accounts Receivable, 5 Yr. CAGR %	0.59	3.46	2.79	3.23	5.74
Inventory, 5 Yr. CAGR %	-0.87	0.15	2.45	5.1	10.4
Net Property, Plant and Equip., 5 Yr. CAGR %	2.17	2.11	0.8	1.6	2.48
Total Assets, 5 Yr. CAGR %	3.38	4.01	4.63	5.92	8.55
Tangible Book Value, 5 Yr. CAGR %	-18.38	0.51	16.73	53.25	10.74
Common Equity, 5 Yr. CAGR %	0.57	2.72	5.09	7.8	7.18
Cash From Operations, 5 Yr. CAGR %	2.1	9.73	2.91	4.21	3.12
Capital Expenditures, 5 Yr. CAGR %	-6.12	-3.1	-8.03	-7.3	2.79
Levered Free Cash Flow, 5 Yr. CAGR %	1.48	13.26	13.28	2.93	-10.99
Unlevered Free Cash Flow, 5 Yr. CAGR %	2.04	13.49	13.52	3.27	-9.55
Dividend Per Share, 5 Yr. CAGR %	5.47	1.49	6.07	5.28	4.73